中等量静脉液体复苏与脓毒症死亡率降低相关
该研究为Premier医疗数据库的回顾性分析,纳入2016年1月1日至2019年12月31日美国612家医院中从急诊科收入ICU的脓毒症及脓毒性休克患者190,682例。基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),但实际给予量变异很大(95%范围1.7-7.4 L)。按主治医师实践分为五组后,中等量组(4.0 L;IQR 2.4-5.1 L)的风险校正死亡率较极低量组(1.6 L;IQR 1.0-2.5 L)或极高量组(6.1 L;IQR 4.0-9.0 L)降低2.5%,p<0.01;医院内医师间差异而非医院间实践差异解释了观察到的变异。作者认为中等量液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。
要点
- 在190,682例脓毒症及脓毒性休克患者中,中等量静脉液体组(4.0 L;IQR 2.4-5.1 L)风险校正死亡率较极低量组(1.6 L;IQR 1.0-2.5 L)或极高量组(6.1 L;IQR 4.0-9.0 L)降低2.5%,p<0.01。
- 基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),但实际给予量变异很大(95%范围1.7-7.4 L)。
- 按主治医师实践分为五组后,医院内医师间差异而非医院间实践差异解释了静脉液体量的变异。
- 作者认为中等量静脉液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。
适用人群与场景
- 2016年1月1日至2019年12月31日从急诊科收入ICU的脓毒症及脓毒性休克患者,共190,682例,来自美国612家医院。
研究设计与关键结果
- 研究设计为Premier医疗数据库的回顾性分析,纳入美国612家医院190,682例从急诊科收入ICU的脓毒症及脓毒性休克患者。
- 基于患者特征和病情严重程度预测的静脉液体量窄幅均值为3.6-4.5 L(95%范围),实际给予量95%范围为1.7-7.4 L。
- 按主治医师实践分为五组:中等量组液体量4.0 L(IQR 2.4-5.1 L),极低量组1.6 L(IQR 1.0-2.5 L),极高量组6.1 L(IQR 4.0-9.0 L)。
- 中等量组风险校正死亡率较极低量组或极高量组降低2.5%,p<0.01。
- 医院内和医院间静脉液体复苏实践分析显示,医院内医师间变异而非医院间实践差异解释了观察到的变异。
证据类型、等级与局限
- 证据类型:回顾性分析(Premier医疗数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为中等量静脉液体复苏与脓毒症死亡率降低相关,应在未来随机对照试验中检验。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Significant practice variation exists in the amount of resuscitative IV fluid given to patients with sepsis. Current research suggests equipoise between a tightly restrictive or more liberal strategy but data is lacking on a wider range of resuscitation practices. We sought to examine the relationship between a wide range of fluid resuscitation practices and sepsis mortality and then identify the primary driver of this practice variation.
DESIGN: Retrospective analysis of the Premier Healthcare Database.
SETTING: Six hundred twelve U.S. hospitals.
PATIENTS: Patients with sepsis and septic shock admitted from the emergency department to the ICU from January 1, 2016, to December 31, 2019.
INTERVENTIONS: The volume of resuscitative IV fluid administered before the end of hospital day- 1 and mortality.
MEASUREMENTS AND MAIN RESULTS: In total, 190,682 patients with sepsis and septic shock were included in the analysis. Based upon patient characteristics and illness severity, we predicted that physicians should prescribe patients with sepsis a narrow mean range of IV fluid (95% range, 3.6-4.5 L). Instead, we observed wide variation in the mean IV fluids administered (95% range, 1.7-7.4 L). After splitting the patients into five groups based upon attending physician practice, we observed patients in the moderate group (4.0 L; interquartile range [IQR], 2.4-5.1 L) experienced a 2.5% reduction in risk-adjusted mortality compared with either the very low (1.6 L; IQR, 1.0-2.5 L) or very high (6.1 L; IQR, 4.0-9.0 L) fluid groups p < 0.01). An analysis of within- and between-hospital IV fluid resuscitation practices showed that physician variation within hospitals instead of practice differences between hospitals accounts for the observed variation.
CONCLUSIONS: Individual physician practice drives excess variation in the amount of IV fluid given to patients with sepsis. A moderate approach to IV fluid resuscitation is associated with decreased sepsis mortality and should be tested in future randomized controlled trials.
参考来源
- Corl KA, Levy MM, Holder AL, et al. Moderate IV Fluid Resuscitation Is Associated With Decreased Sepsis Mortality. Crit Care Med. 2024. PMID: 39177437. doi:10.1097/CCM.0000000000006394
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。